{"nctId":"NCT01145625","briefTitle":"Clinical Trial in Females With Female Pattern Hair Loss","startDateStruct":{"date":"2010-06"},"conditions":["Alopecia"],"count":322,"armGroups":[{"label":"5% MTF","type":"EXPERIMENTAL","interventionNames":["Drug: 5% Minoxidil"]},{"label":"2% MTS","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: 2% Minoxidil"]}],"interventions":[{"name":"5% Minoxidil","otherNames":[]},{"name":"2% Minoxidil","otherNames":["ROGAINEÂ®"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* females, age 18 or older in general good health\n* exhibits female pattern hair loss\n* signs and dates an informed consent document\n* agrees to use an adequate method of birth control; if of childbearing potential\n* shows a negative urine pregnancy test at Screening Visit\n* is willing to maintain the same hair style, hair color, and hair regimen throughout the study\n* is willing and able to comply with scheduled visits, treatment plan, laboratory tests and other trial procedures\n\nExclusion Criteria:\n\n* hypersensitivity to the study product, or any ingredients of the study product\n* known allergy to hair dye, or hair dye components\n* clinically relevant history of hypotension\n* untreated or uncontrolled hypertension\n* pregnant, planning a pregnancy or nursing a child\n* history of hair transplants\n* currently use hair weaves or non-breathable wigs\n* dermatologic disorders of the scalp that require chronic use of medication for control\n* other types or history of hair loss\n* enrolled in any other investigational medication (drug) study currently, or within the last 6 months","healthyVolunteers":false,"sex":"FEMALE","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Target Area Hair Count (TAHC)","description":"Number of hairs in the area being examined as measured by macrophotography.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"167.3","spread":"55.0"},{"groupId":"OG001","value":"169.7","spread":"58.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"192.8","spread":"57.0"},{"groupId":"OG001","value":"194.4","spread":"64.7"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"23.8","spread":"24.7"},{"groupId":"OG001","value":"23.7","spread":"22.9"}]}]}]},{"type":"SECONDARY","title":"Target Area Hair Count (TAHC)","description":"Number of hairs in the area being examined as measured by macrophotography","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"167.3","spread":"55.0"},{"groupId":"OG001","value":"169.7","spread":"58.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"190.7","spread":"56.9"},{"groupId":"OG001","value":"191.8","spread":"62.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"22.5","spread":"22.8"},{"groupId":"OG001","value":"24.9","spread":"26.0"}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Target Area Hair Count (TAHC)","description":"Number of hairs in the area being examined as measured by macrophotography.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"167.3","spread":"55.0"},{"groupId":"OG001","value":"169.7","spread":"58.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"189.1","spread":"55.8"},{"groupId":"OG001","value":"186.9","spread":"61.1"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"19.4","spread":"21.5"},{"groupId":"OG001","value":"18.1","spread":"23.4"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":8,"n":161},"commonTop":["Nasopharyngitis","Weight increased","Headache","Upper respiratory tract infection","Sinusitis"]}}}